File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Negligible immunogenicity of induced pluripotent stem cells derived from human skin fibroblasts

TitleNegligible immunogenicity of induced pluripotent stem cells derived from human skin fibroblasts
Authors
Issue Date2014
PublisherPublic Library of Science. The Journal's web site is located at http://www.plosone.org/home.action
Citation
PLOS One, 2014, v. 11 n. 9, article no. e114949 How to Cite?
AbstractHuman induced pluripotent stem cells (hiPSCs) have potential applications in cell replacement therapy and regenerative medicine. However, limited information is available regarding the immunologic features of iPSCs. In this study, expression of MHC and T cell co-stimulatory molecules in hiPSCs, and the effects on activation, proliferation and cytokine production in allogeneic human peripheral blood mononuclear cells were examined. We found that no-integrate hiPSCs had no MHC-II and T cell co-stimulatory molecules expressions but had moderate level of MHC-I and HLA-G expressions. In contrast to human skin fibroblasts (HSFs) which significantly induced allogeneic T cell activation and proliferation, hiPSCs failed to induce allogeneic CD45+ lymphocyte and CD8+ T cell activation and proliferation but could induce a low level of allogeneic CD4+ T cell proliferation. Unlike HSFs which induced allogeneic lymphocytes to produce high levels of IFN-γ, TNF-α and IL-17, hiPSCs only induced allogeneic lymphocytes to produce IL-2 and IL-10, and promote IL-10-secreting regulatory T cell (Treg) generation. Our study suggests that the integration-free hiPSCs had low or negligible immunogenicity, which may result from their induction of IL-10-secreting Treg.
Persistent Identifierhttp://hdl.handle.net/10722/211885
ISSN
2023 Impact Factor: 2.9
2023 SCImago Journal Rankings: 0.839
PubMed Central ID
ISI Accession Number ID
Errata

 

DC FieldValueLanguage
dc.contributor.authorLu, Q-
dc.contributor.authorYu, M-
dc.contributor.authorShen, C-
dc.contributor.authorChen, X-
dc.contributor.authorFeng, T-
dc.contributor.authorYao, Y-
dc.contributor.authorLi, J-
dc.contributor.authorLi, H-
dc.contributor.authorTu, W-
dc.date.accessioned2015-07-21T02:14:51Z-
dc.date.available2015-07-21T02:14:51Z-
dc.date.issued2014-
dc.identifier.citationPLOS One, 2014, v. 11 n. 9, article no. e114949-
dc.identifier.issn1932-6203-
dc.identifier.urihttp://hdl.handle.net/10722/211885-
dc.description.abstractHuman induced pluripotent stem cells (hiPSCs) have potential applications in cell replacement therapy and regenerative medicine. However, limited information is available regarding the immunologic features of iPSCs. In this study, expression of MHC and T cell co-stimulatory molecules in hiPSCs, and the effects on activation, proliferation and cytokine production in allogeneic human peripheral blood mononuclear cells were examined. We found that no-integrate hiPSCs had no MHC-II and T cell co-stimulatory molecules expressions but had moderate level of MHC-I and HLA-G expressions. In contrast to human skin fibroblasts (HSFs) which significantly induced allogeneic T cell activation and proliferation, hiPSCs failed to induce allogeneic CD45+ lymphocyte and CD8+ T cell activation and proliferation but could induce a low level of allogeneic CD4+ T cell proliferation. Unlike HSFs which induced allogeneic lymphocytes to produce high levels of IFN-γ, TNF-α and IL-17, hiPSCs only induced allogeneic lymphocytes to produce IL-2 and IL-10, and promote IL-10-secreting regulatory T cell (Treg) generation. Our study suggests that the integration-free hiPSCs had low or negligible immunogenicity, which may result from their induction of IL-10-secreting Treg.-
dc.languageeng-
dc.publisherPublic Library of Science. The Journal's web site is located at http://www.plosone.org/home.action-
dc.relation.ispartofPLoS ONE-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.titleNegligible immunogenicity of induced pluripotent stem cells derived from human skin fibroblasts-
dc.typeArticle-
dc.identifier.emailTu, W: wwtu@hku.hk-
dc.identifier.authorityTu, W=rp00416-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.1371/journal.pone.0114949-
dc.identifier.pmid25503995-
dc.identifier.pmcidPMC4263724-
dc.identifier.scopuseid_2-s2.0-84916891554-
dc.identifier.hkuros244597-
dc.identifier.volume11-
dc.identifier.issue9-
dc.identifier.isiWOS:000347146700075-
dc.publisher.placeUnited States-
dc.relation.erratumdoi:10.1371/journal.pone.0120834-
dc.identifier.issnl1932-6203-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats